A neonate with idiopathic hyperaldosteronism

A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric nephrology (Berlin, West) West), 1991-11, Vol.5 (6), p.680-684
Hauptverfasser: VEENHOVEN, R. H, VANDE WALLE, J. G, DONCKERWOLCKE, R. A, WIT, J. M, GRIFFIVEN, A. W, DERKX, F. H, SCHALEKAMP, M. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 684
container_issue 6
container_start_page 680
container_title Pediatric nephrology (Berlin, West)
container_volume 5
creator VEENHOVEN, R. H
VANDE WALLE, J. G
DONCKERWOLCKE, R. A
WIT, J. M
GRIFFIVEN, A. W
DERKX, F. H
SCHALEKAMP, M. A
description A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.
doi_str_mv 10.1007/BF00857870
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72600130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72600130</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-efafa01adf14afe0cf40365b7e907d165d50732db0ef3950137524aa46c82d1e3</originalsourceid><addsrcrecordid>eNpFkDtLA0EUhQdRYow29sIWYiGu3nnt7JYxGBUCNgrplpt5kJF9ObNB8u_dkGCqW5zvHC4fIdcUHimAenqeA-RS5QpOyJgKzlJa5MtTMoaC0xQEXZ6Tixi_YYfl2YiMqMqGghqTh2nS2LbB3ia_vl8n3vi2w37tdbLedjZgZdrY29A2PtaX5MxhFe3V4U7I1_zlc_aWLj5e32fTRaqZgj61Dh0CReOoQGdBOwE8kytlC1CGZtJIUJyZFVjHCwmUK8kEosh0zgy1fELu9rtdaH82NvZl7aO2VYXDr5tYKpbB0IIBvN-DOrQxBuvKLvgaw7akUO7UlEc1A3xzWN2samuO6N7FkN8ecowaKxew0T7-YxKYKJTgfyd6ago</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72600130</pqid></control><display><type>article</type><title>A neonate with idiopathic hyperaldosteronism</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>VEENHOVEN, R. H ; VANDE WALLE, J. G ; DONCKERWOLCKE, R. A ; WIT, J. M ; GRIFFIVEN, A. W ; DERKX, F. H ; SCHALEKAMP, M. A</creator><creatorcontrib>VEENHOVEN, R. H ; VANDE WALLE, J. G ; DONCKERWOLCKE, R. A ; WIT, J. M ; GRIFFIVEN, A. W ; DERKX, F. H ; SCHALEKAMP, M. A</creatorcontrib><description>A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.</description><identifier>ISSN: 0931-041X</identifier><identifier>EISSN: 1432-198X</identifier><identifier>DOI: 10.1007/BF00857870</identifier><identifier>PMID: 1768577</identifier><identifier>CODEN: PENED3</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Aldosterone - blood ; Aldosterone - urine ; Biological and medical sciences ; Calcium - metabolism ; Gastrointestinal Diseases - metabolism ; Hormones. Endocrine system ; Humans ; Hyperaldosteronism - drug therapy ; Hyperaldosteronism - metabolism ; Hypokalemia - drug therapy ; Hypokalemia - metabolism ; Infant, Newborn ; Magnesium Hydroxide - therapeutic use ; Male ; Medical sciences ; Nifedipine - therapeutic use ; Pharmacology. Drug treatments ; Renin-Angiotensin System - physiology ; Spironolactone - therapeutic use</subject><ispartof>Pediatric nephrology (Berlin, West), 1991-11, Vol.5 (6), p.680-684</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-efafa01adf14afe0cf40365b7e907d165d50732db0ef3950137524aa46c82d1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5024974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1768577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VEENHOVEN, R. H</creatorcontrib><creatorcontrib>VANDE WALLE, J. G</creatorcontrib><creatorcontrib>DONCKERWOLCKE, R. A</creatorcontrib><creatorcontrib>WIT, J. M</creatorcontrib><creatorcontrib>GRIFFIVEN, A. W</creatorcontrib><creatorcontrib>DERKX, F. H</creatorcontrib><creatorcontrib>SCHALEKAMP, M. A</creatorcontrib><title>A neonate with idiopathic hyperaldosteronism</title><title>Pediatric nephrology (Berlin, West)</title><addtitle>Pediatr Nephrol</addtitle><description>A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.</description><subject>Aldosterone - blood</subject><subject>Aldosterone - urine</subject><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>Gastrointestinal Diseases - metabolism</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Hyperaldosteronism - drug therapy</subject><subject>Hyperaldosteronism - metabolism</subject><subject>Hypokalemia - drug therapy</subject><subject>Hypokalemia - metabolism</subject><subject>Infant, Newborn</subject><subject>Magnesium Hydroxide - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nifedipine - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Spironolactone - therapeutic use</subject><issn>0931-041X</issn><issn>1432-198X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDtLA0EUhQdRYow29sIWYiGu3nnt7JYxGBUCNgrplpt5kJF9ObNB8u_dkGCqW5zvHC4fIdcUHimAenqeA-RS5QpOyJgKzlJa5MtTMoaC0xQEXZ6Tixi_YYfl2YiMqMqGghqTh2nS2LbB3ia_vl8n3vi2w37tdbLedjZgZdrY29A2PtaX5MxhFe3V4U7I1_zlc_aWLj5e32fTRaqZgj61Dh0CReOoQGdBOwE8kytlC1CGZtJIUJyZFVjHCwmUK8kEosh0zgy1fELu9rtdaH82NvZl7aO2VYXDr5tYKpbB0IIBvN-DOrQxBuvKLvgaw7akUO7UlEc1A3xzWN2samuO6N7FkN8ecowaKxew0T7-YxKYKJTgfyd6ago</recordid><startdate>199111</startdate><enddate>199111</enddate><creator>VEENHOVEN, R. H</creator><creator>VANDE WALLE, J. G</creator><creator>DONCKERWOLCKE, R. A</creator><creator>WIT, J. M</creator><creator>GRIFFIVEN, A. W</creator><creator>DERKX, F. H</creator><creator>SCHALEKAMP, M. A</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199111</creationdate><title>A neonate with idiopathic hyperaldosteronism</title><author>VEENHOVEN, R. H ; VANDE WALLE, J. G ; DONCKERWOLCKE, R. A ; WIT, J. M ; GRIFFIVEN, A. W ; DERKX, F. H ; SCHALEKAMP, M. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-efafa01adf14afe0cf40365b7e907d165d50732db0ef3950137524aa46c82d1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Aldosterone - blood</topic><topic>Aldosterone - urine</topic><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>Gastrointestinal Diseases - metabolism</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Hyperaldosteronism - drug therapy</topic><topic>Hyperaldosteronism - metabolism</topic><topic>Hypokalemia - drug therapy</topic><topic>Hypokalemia - metabolism</topic><topic>Infant, Newborn</topic><topic>Magnesium Hydroxide - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nifedipine - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Spironolactone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VEENHOVEN, R. H</creatorcontrib><creatorcontrib>VANDE WALLE, J. G</creatorcontrib><creatorcontrib>DONCKERWOLCKE, R. A</creatorcontrib><creatorcontrib>WIT, J. M</creatorcontrib><creatorcontrib>GRIFFIVEN, A. W</creatorcontrib><creatorcontrib>DERKX, F. H</creatorcontrib><creatorcontrib>SCHALEKAMP, M. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric nephrology (Berlin, West)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VEENHOVEN, R. H</au><au>VANDE WALLE, J. G</au><au>DONCKERWOLCKE, R. A</au><au>WIT, J. M</au><au>GRIFFIVEN, A. W</au><au>DERKX, F. H</au><au>SCHALEKAMP, M. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A neonate with idiopathic hyperaldosteronism</atitle><jtitle>Pediatric nephrology (Berlin, West)</jtitle><addtitle>Pediatr Nephrol</addtitle><date>1991-11</date><risdate>1991</risdate><volume>5</volume><issue>6</issue><spage>680</spage><epage>684</epage><pages>680-684</pages><issn>0931-041X</issn><eissn>1432-198X</eissn><coden>PENED3</coden><abstract>A boy with functional abnormalities of the gastro-intestinal tract, hyponatraemia, hypokalaemia and hypertension is described. All symptoms developed within the first 2 months of life. Increased aldosterone levels were associated with suppressed values in the renin-angiotensin system. The diagnosis of idiopathic hyperaldosteronism was made because of adrenal hyperplasia and the failure to suppress aldosterone to undetectable levels with glucocorticoids. Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone. However, the combination of spironolactone with nifedipine decreased blood pressure. Abnormal gastro-intestinal motility was corrected by low doses of oral magnesium hydroxide. To assess intracellular calcium homeostasis, the patient's peripheral blood mononuclear cells were incubated with increasing concentrations of calcium. As these cells failed to maintain physiological calcium concentration, a defect in intracellular calcium homeostasis was suspected.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>1768577</pmid><doi>10.1007/BF00857870</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0931-041X
ispartof Pediatric nephrology (Berlin, West), 1991-11, Vol.5 (6), p.680-684
issn 0931-041X
1432-198X
language eng
recordid cdi_proquest_miscellaneous_72600130
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Aldosterone - blood
Aldosterone - urine
Biological and medical sciences
Calcium - metabolism
Gastrointestinal Diseases - metabolism
Hormones. Endocrine system
Humans
Hyperaldosteronism - drug therapy
Hyperaldosteronism - metabolism
Hypokalemia - drug therapy
Hypokalemia - metabolism
Infant, Newborn
Magnesium Hydroxide - therapeutic use
Male
Medical sciences
Nifedipine - therapeutic use
Pharmacology. Drug treatments
Renin-Angiotensin System - physiology
Spironolactone - therapeutic use
title A neonate with idiopathic hyperaldosteronism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20neonate%20with%20idiopathic%20hyperaldosteronism&rft.jtitle=Pediatric%20nephrology%20(Berlin,%20West)&rft.au=VEENHOVEN,%20R.%20H&rft.date=1991-11&rft.volume=5&rft.issue=6&rft.spage=680&rft.epage=684&rft.pages=680-684&rft.issn=0931-041X&rft.eissn=1432-198X&rft.coden=PENED3&rft_id=info:doi/10.1007/BF00857870&rft_dat=%3Cproquest_cross%3E72600130%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72600130&rft_id=info:pmid/1768577&rfr_iscdi=true